Biotech SPAC takes IPO goal down a notch; Africa’s top health agency warns against monkeypox vaccine hoarding
A blank check SPAC was gunning to raise $100 million when it filed an S-1 in April. Now, it has set its sights a little …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
